About Photocure ASA Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
The "Global Enzyme Contract Manufacturing Market (2024 Edition): Analysis By Source (Plant, Animal, Microbe), By Application, By End-Use, By Region: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering....
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to participate in...
Shoulder Innovations, a leader in the shoulder replacement implant market, is proud to announce the launch of its latest product: the InSettm 95 Humeral Stem. This product is designed to enhance surgical outcomes and improve patient recovery for...
mBIOTA Labs, a medical food company revolutionizing oral nutrition through their proprietary palatable elemental diet, mBIOTA Elementaltm, today announced the initial study results of their first prospective clinical trial assessing the efficacy of...
Epicutis®, a professional, medical-grade luxury skincare line by Signum Biosciences, is thrilled to announce its partnership with the Four Seasons Hotel Toronto along with new Epicutis® Lipid Recovery Mask for Eyes, developed in collaboration with...
Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in...